Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

U.S. Intravenous Solutions Market – Insights

Intravenous solutions (IV) are administered to patients to transfer sugar, salt and water directly into venous circulation. IV solutions and electrolytes are used for fluid resuscitation, routine maintenance, replacement, and redistribution. Nowadays, intravenous drugs, nutrition and mixed solutions have become an integral part of modern therapy. Adoption of inorganic growth strategies such as collaborations and acquisitions by key players in order to expand their portfolio of intravenous solutions is expected to drive growth of the U.S. intravenous solutions market. For instance, in April 2015, Baxter International Inc. and France-based Laboratoire Aguettant SAS, entered into a licensing and distribution agreement for trace elements, which are essential micronutrients used in parenteral nutrition (PN) therapy.

U.S. intravenous solutions market size was estimated to be valued at US$ 2,665.5 million in 2019 and is expected to witness a CAGR of 6.4% over the forecast period (2019 – 2027).

U.S. Intravenous Solutions Market Share (%) Analysis, By Solution Type, 2019

U.S. Intravenous Solution  | Coherent Market Insights

Source: Coherent Market Insights Analysis (2020)

Increasing Launches and Regulatory Approvals of Intravenous Solution Injections is expected to Drive Growth of the US Intravenous Solutions Market

Increasing approvals of intravenous solution injections from regulatory authorities are expected to drive the U.S. intravenous solution market growth over the forecast period. In July 2019, Baxter International Inc. announced that the US Food and Drug Administration (FDA) approved its Myxredlin (Insulin Human in 0.9% Sodium Chloride Injection). Myxredlin (Insulin Human in 0.9% Sodium Chloride Injection) is the first and only ready-to-use insulin for IV infusion in hospitals and other acute care settings.

Furthermore, in January 2018, Baxter International Inc. announced that the US Food and Drug Administration (FDA) approved its Bivalirudin in 0.9% Sodium Chloride Injection (Bivalirudin). Bivalirudin is a specific and direct thrombin inhibitor indicated as an anticoagulant in patients undergoing percutaneous coronary intervention (PCI), a common non-surgical procedure to treat blocked or narrowed blood vessels in the heart.

Launches of new intravenous solution injections for treatment of various diseases such as dehydration, gastrointestinal diseases are expected to boost the market growth over the forecast period. For instance, in 2017, Fresenius Kabi USA, LLC, provider of medicines and technologies for infusion, transfusion, and clinical nutrition, launched Vecuronium Bromide for Injection in the U.S. The drug is indicated for maintenance of neuromuscular blockade and paralysis.

U.S. Intravenous Solutions Market - Restraints

Growth of the U.S. intravenous solution market is expected to be hampered over the forecast period, owing to increasing FDA recalls of IV products. For instance, in August 2018, the U.S. FDA recalled Becton Dickinson & Company’s NEXIVA Closed IV Catheter System Dual Port 18GA 1.25 IN (BD Nexiva catheter) due to failure in the needle tip shield/safety mechanism.

US Intravenous Solutions Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2027

U.S. Intravenous Solution  | Coherent Market Insights

Source: Coherent Market Insights Analysis (2020)

U.S. Intravenous Solutions Market - Competitive Landscape

  • Key players operating in the U.S Intravenous Solution Market include Baxter International Inc., ICU Medical, Inc., B. Braun Melsungen Ag and Grifols, S.A.

Intravenous solutions are fluids which are administrated directly into the venous circulation. These fluids are sterile, nonpyrogenic solutions used for fluid replenishment and caloric supply in single dose container for intravenous administration. Intravenous therapy is ideal for patients suffering from nutritional deficiency and dehydration. There are various types of intravenous solutions available in the market such as sodium chloride, lactated ringers, dextrose in water, and others.

Market Dynamics

Increasing prevalence of diarrhea is expected to drive the U.S. intravenous solutions market growth during the forecast period. For instance, according to University of Texas Health Science Center 2014, around 179 million cases of acute diarrhea occur each year in the U.S. and most of those cases are entirely preventable. The main causes of diarrheal infections include norovirus outbreak and foodborne pathogens, with most infections stemming from contaminated leafy green vegetables.

However, increasing shortage of IV solutions in the U.S. is one of the factors that is expected to hinder growth of the market. Due to hurricane strike in Puerto Rico in 2017, the U.S. witnessed shortage of IV. This is owing to Puerto Rico being one of the major producers of IV bags. The U.S government is still working on ways to regain the production of IV fluids to meet the rising demand for IV fluids in the U.S.

Key features of the study:

  • This report provides in-depth analysis of the U.S. intravenous solutions market, market size (US$ Mn), and Compound Annual Growth Rate (CAGR (%)) for the forecast period: 2019 -2027, considering 2018 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
  • It profiles key players in the U.S. intravenous solutions market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key players covered as a part of this study include Baxter International Inc., ICU Medical, Inc., B. Braun Melsungen Ag and Grifols, S.A.
  • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to future product launches, government initiatives, technological up-gradation, market expansion, and marketing tactics
  • U.S. intravenous solutions market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for U.S. intravenous solutions market, research and consulting firms, new entrants, and financial analysts

Detailed Segmentation:

  • U.S. Intravenous Solutions Market, By Solution Type:
    • Saline
      • Normal Saline (0.9% NaCl)
      • Hypertonic Saline
    • Dextran
    • Lactated Ringer’s
    • Amino Acid
    • Vitamins & Minerals
    • Heparin and Trace Elements
    • Mixed Solutions
  •  U.S. Intravenous Solutions Market, By Bag Type:
    • Large Volume Bags (greater than 250ml)
    • Small Volume Bags (less than 250ml)
  • U.S. Intravenous Solutions Market, By Application Type:
    • Basic IV Solution
    • Nutritional IV Solution
    • Blood IV Solution
    • Drug IV Solution
    • Irrigation IV Solution
  • U.S. Intravenous Solutions Market, By End User:
    • Hospitals
    • Clinics
    • Ambulatory Surgery Centers
    • Home Care Settings
  • Company Profiles
    • Baxter International Inc.
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
    • ICU Medical, Inc.
    • Braun Melsungen Ag
    • Grifols, S.A.

 “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objective and Assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Overview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Solution Type
      • Market Snippet, By Bag Type
      • Market Snippet, By Application
      • Market Snippet, By End User
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Market Trends
    • Key Developments
    • Regulatory Landscape
    • Epidemiology Analysis
    • Porter’s Five Forces model
  4. U.S. Intravenous Solutions Market, By Solution Type, 2016 – 2027, (US$ Million)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Saline
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
        • Normal Saline (0.9% NaCl)
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
        • Hypertonic Saline
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Dextran
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Lactated Ringer’s
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Amino Acid
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Vitamins & Minerals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Heparin and trace elements
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Mixed Solutions
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
  5. U.S. Intravenous Solutions Market, By Bag Type, 2016 – 2027, (US$ Million)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Large Volume Bags (greater than 250ml)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Small Volume Bags (less than 250ml)
      • Introduction    
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
  6. U.S. Intravenous Solutions Market, By Application, 2016 – 2027, (US$ Million)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Basic IV Solution
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Nutritional IV Solution
      • Introduction    
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Blood IV Solution
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Drug IV Solution
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Irrigation IV Solution
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
  7. U.S. Intravenous Solutions Market, By End User , 2016 – 2027, (US$ Million)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Clinics
      • Introduction    
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Ambulatory Surgery Centers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Home care Settings
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
  8. Competitive Landscape
    • Company Profiles
      • Baxter International Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • ICU Medical, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Braun Melsungen Ag
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Grifols, S.A.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
    • Analyst Views
  9. Section
    • References
    • Research Methodology
    • About Us and Sales Contact

*Browse 12 market data tables and 24 figures on "Intravenous Solutions Market” - U.S.  forecast to 2027”

Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner